Compound aluminum sulfate

To evaluate the safety and efficacy of local injection of aluminum sulfate compound injection compared with TURBT for the treatment of non-muscle invasive bladder cancer (Ta/T1 stage) or benign bladder tumors. This is a multicenter, randomized, open, parallel, non-inferiority trial design. The main focus is on the comparison of the recurrence rate between TURBT surgery and aluminum sulfate compound injection in the third year.